Dr. Shirit Einav, MD

Dr. Einav practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Einav's NPI, 1467688002, was assigned on June 10, 2009. Dr. Einav graduated from Tel Aviv University Sackler in 1998. Dr. Einav holds California license A81396.

Dr. Einav's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Einav's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Einav to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Einav's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Einav practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Einav's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Einav is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Einav's licenses on file in 2 states: California and Massachusetts.

CMS data shows 40 Medicare services from Dr. Einav across 1 procedure code in 2024, for 15 Medicare patients. Medicare paid $4,258 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 15 Medicare patients who saw Dr. Einav in 2024. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Einav's median patient age at 56, with 40% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Einav for performance year 2024, reported as part of a group. Dr. Einav accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 71 papers to Dr. Einav, published from 2003 to 2024. 2018 was the busiest year, with 13. The most frequent topics are Antiviral Agents, Dengue Virus and Cell Line. Dr. Einav has published most often in Antiviral Res. Dr. Einav's most frequent co-authors are Makeda Lucretia Robinson, MD, Jeffrey Scott Glenn, MD, PhD and Benjamin Alan Pinsky, MD, PhD.

CMS Open Payments shows 16 general payments to Dr. Einav from 1 drug or device company in 2025. Consulting fees make up the largest share, 75% of the total. Emergent Biosolutions Inc. paid the most, $9,223.

Dr. Einav graduated from Tel Aviv University Sackler in 1998.

Dr. Einav is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.